These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7972104)

  • 1. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity.
    Lowin B; Beermann F; Schmidt A; Tschopp J
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11571-5. PubMed ID: 7972104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.
    Kägi D; Ledermann B; Bürki K; Seiler P; Odermatt B; Olsen KJ; Podack ER; Zinkernagel RM; Hengartner H
    Nature; 1994 May; 369(6475):31-7. PubMed ID: 8164737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin and its role in T lymphocyte-mediated cytolysis.
    Lowin B; Krähenbühl O; Müller C; Dupuis M; Tschopp J
    Experientia; 1992 Oct; 48(10):911-20. PubMed ID: 1426142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perforin and lymphocyte-mediated cytolysis.
    Liu CC; Persechini PM; Young JD
    Immunol Rev; 1995 Aug; 146():145-75. PubMed ID: 7493752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
    Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD
    J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer Cell Group 7 Sequence in Cytotoxic Cells Optimizes Exocytosis of Lytic Granules Essential for the Perforin-Dependent, but Not Fas Ligand-Dependent, Cytolytic Pathway.
    Morikawa Y; Murakami M; Kondo H; Nemoto N; Iwabuchi K; Eshima K
    Immunohorizons; 2021 Apr; 5(4):234-245. PubMed ID: 33911019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity.
    Lowin B; Peitsch MC; Tschopp J
    Curr Top Microbiol Immunol; 1995; 198():1-24. PubMed ID: 7774276
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes.
    Lowin B; Mattman C; Hahne M; Tschopp J
    Int Immunol; 1996 Jan; 8(1):57-63. PubMed ID: 8671589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.
    Lowin B; Hahne M; Mattmann C; Tschopp J
    Nature; 1994 Aug; 370(6491):650-2. PubMed ID: 7520535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability.
    Bochan MR; Goebel WS; Brahmi Z
    Cell Immunol; 1995 Sep; 164(2):234-9. PubMed ID: 7656332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
    Berke G; Rosen D; Ronen D
    Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells.
    Simon MM; Hausmann M; Tran T; Ebnet K; Tschopp J; ThaHla R; Müllbacher A
    J Exp Med; 1997 Nov; 186(10):1781-6. PubMed ID: 9362539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human perforin in a mouse cytotoxic T lymphocyte cell line: evidence for perturbation of granule-mediated cytotoxicity.
    Thia KY; Smyth MJ; Trapani JA
    J Leukoc Biol; 1993 Dec; 54(6):528-33. PubMed ID: 8245705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High activity of N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and cytolytic perforin in cloned cell lines is not demonstrable in in-vivo-induced cytotoxic effector cells.
    Dennert G; Anderson CG; Prochazka G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5004-8. PubMed ID: 2955414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing by cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation.
    Trapani JA; Smyth MJ
    Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():201-8. PubMed ID: 8349302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
    Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
    J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.